Traditionally, hepatitis B virus (HBV) is classified into 4 subtypes or serotypes (adr, adw, ayr, and ayw) based on antigenic determinants of the hepatitis B surface antigen.1 These subtypes can be further classified into 9 serotypes (ayw1, ayw2, ayw3, ayw4, ayr, adw2, adw4, adrq , and adrq ).2 Epidemiologic studies found that the prevalence of these serotypes varies in different parts of the world. In addition, antibody to the common determinant, “a,” confers protection against all serotypes. To date, there has been very little data on the clinical significance of HBV serotypes. Advances in molecular biology techniques revealed significant diversities in sequences of HBV isolates, accounting for the allelic differences among the 4 major HBV serotypes. Based on an intergroup divergence of 8% or more in the complete nucleotide sequence, HBV can be classified into 7 genotypes A-G.3-5 However, genotyping can be accomplished based on a partial sequence of the HBV genome such as the pre-S or S gene. Several methods have been used for HBV genotyping including direct sequencing, restriction fragment length polymorphism, line probe assay, and enzyme-linked immunoassay. Contrary to hepatitis C virus genotyping, HBV genotyping is a research tool that is only beginning to gain popularity among researchers in hepatitis B. Whether HBV genotyping will constitute part of the clinical evaluation of hepatitis B patients depends on the availability of simple and inexpensive tests and the relevance of the information gained. Currently, restriction fragment length polymorphism is the most commonly used method for HBV genotyping. A line probe assay similar to that used for hepatitis C virus genotyping is also available. These assays can be easily applied in clinical diagnostic laboratories. The key issue is, does knowledge of the HBV genotype help in patient management? The specific questions include, (1) Is there a correlation between HBV genotype and HBV replication, activity of liver disease, clinical outcome, and treatment response? (2) What is the predominant HBV genotype in each country? Is the geographical distribution of HBV genotypes related to the endemicity of HBV infection? (3) Is there a correlation between HBV genotype and risk of progression to chronic infection? (4) Does infection with one HBV genotype confer protection against infection with other HBV genotypes? Answers to some of the questions raised are beginning to emerge but many of the answers are based on a few studies in selected patient populations. Current information on the geographical distribution of HBV genotypes is summarized in Table 1. However, existing information is incomplete. As an example, earlier studies suggested that HBV genotype A is predominant in the United States. A recent study indicated that HBV genotype G is also prevalent because it was present in 11 of 82 patients from the state of Georgia.5 However, in an ongoing study involving 17 liver centers across the United States, we found all 7 HBV genotypes: A (33%), B (21%), C (34%), D (9%), E (1%), F (1%), and G (1%) (personal observations). HBV genotype A was more common among whites and African Americans, whereas genotypes B and C were predominantly found in Asian Americans. The high prevalence of HBV genotypes B and C among Asians raise the possibility that HBV genotype may be related to the endemicity of HBV infection. To date, there has been no study on the relationship between HBV genotype and mode of transmission. One study in Switzerland found that genotype A was more common among patients with chronic hepatitis B, whereas genotype D was more prevalent among patients with resolving acute hepatitis B suggesting that HBV genotype A was associated with a higher rate of chronic HBV infection.6 However, this study involved a total of 65 patients only and confounding factors such as age at infection, gender, mode of transmission, and coinfection with other hepatitis virus or human immunodeficiency virus were not analyzed. HBV genotypes may contribute to the wide range in prevalence of HBV infection in different parts of the world through differences in rates of replication and abilities to evade immune clearance, but studies comparing Abbreviations: HBV, hepatitis B virus; HBeAg, hepatitis B e antigen. From the Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI. Received January 23, 2002; accepted February 21, 2002. Address reprint requests to: Anna S. F. Lok, M.D., Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109. E-mail: aslok@umich.edu; fax: 734-936-7392. Copyright © 2002 by the American Association for the Study of Liver Diseases. 0270-9139/02/3505-0032$35.00/0 doi:10.1053/jhep.2002.33161
[1]
M. Mizokami,et al.
Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan
,
2003,
Intervirology.
[2]
A. Lok,et al.
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.
,
2002,
Gastroenterology.
[3]
T Ichida,et al.
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
,
2001,
Hepatology.
[4]
J. Petersen,et al.
20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw
,
2001,
The Lancet.
[5]
Makoto Nakanishi,et al.
Hepatitis B Virus Genotype Distribution among Chronic Hepatitis B Virus Carriers in Shanghai, China
,
2001,
Intervirology.
[6]
T. Okanoue,et al.
A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C
,
2001,
Hepatology.
[7]
Ding‐Shinn Chen,et al.
Hepatitis B genotypes and the response to interferon therapy.
,
2000,
Journal of hepatology.
[8]
L. Stuyver,et al.
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.
,
2000,
Journal of hepatology.
[9]
Ding‐Shinn Chen,et al.
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.
,
2000,
Gastroenterology.
[10]
C. Mayerat,et al.
Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?
,
1999,
Journal of viral hepatitis.
[11]
C. Hannoun,et al.
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers.
,
1999,
The Journal of infectious diseases.
[12]
M Lindh,et al.
Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method.
,
1997,
The Journal of infectious diseases.
[13]
F. Zoulim,et al.
Analysis of hepatitis B virus genotypes and pre‐core region variability during interferon treatment of HBe antigen negative chronic hepatitis B
,
1996,
Journal of medical virology.
[14]
M. Buti,et al.
Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations
,
1995,
Hepatology.
[15]
U. Akarca,et al.
Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.
,
1994,
Proceedings of the National Academy of Sciences of the United States of America.
[16]
A. Couroucé,et al.
Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes.
,
1994,
Virology.
[17]
Q. Zhang,et al.
Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region
,
1993,
Journal of virology.
[18]
Y. Ohashi,et al.
Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
,
1991,
The American journal of gastroenterology.
[19]
H. Sakugawa,et al.
Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.
,
1988,
The Journal of general virology.
[20]
J. Lemaire,et al.
New Hepatitis B Surface Antigen Subtypes inside the ad Category
,
1978,
Vox sanguinis.
[21]
S. Krugman,et al.
Subtypes of Australia antigen and hepatitis-B virus.
,
1972,
JAMA.
[22]
加藤 秀章.
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G
,
2002
.
[23]
T. Okanoue,et al.
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group.
,
2001,
Hepatology.
[24]
R F Schinazi,et al.
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.
,
2000,
The Journal of general virology.
[25]
D. Blondin,et al.
Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B
,
2000,
Hepatology.